SPMO — INVESCO EXCH TRADED FD TR II

Ownership history in Prostatis Group LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Prostatis Group LLC reported a position in INVESCO EXCH TRADED FD TR II (SPMO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.16% (2025 Q4)
Avg. % of fund
0.89%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 40,644 +10,790 +36.1% 1.16% $4.8M $119.32
2025 Q3 ADDED 29,854 +6,084 +25.6% 0.91% $3.6M $120.77
2025 Q2 REDUCED 23,770 -1,770 -6.9% 0.77% $2.7M $112.02
2025 Q1 INITIATED 25,540 — — 0.75% $2.4M $91.98
% of Fund (quarterly)    SPMO price (monthly, adj. close)

Other funds also holding SPMO

As of 2025 Q4 — sorted by position size

Seros Financial, LLC 15.64% FISCHER INVESTMENT STRATEGIES, LLC 14.0% Triton Wealth Management, PLLC 3Y 10.79% Oxford Wealth Group, LLC 9.8% MAINSTAY CAPITAL MANAGEMENT LLC /ADV 3Y 7Y 9.24% PLANNING ALTERNATIVES LTD /ADV 3Y 7Y 9.1% Family Investment Center, Inc. 3Y 9.07% Redwood Investment Management, LLC 3Y 7Y 8.36% Bull Oak Capital, LLC 7.7% CAPSTONE WEALTH MANAGEMENT GROUP, LLC 3Y 7.15%
← Back to Prostatis Group LLC Holdings